Table 2.

Passing Rates for Quality Measures (%)

	All women (n = 21,780)	All men (n = 646,429)	Difference	P value
LDL < 100 mg/dL	55	68	13	< 0.0001
Clinical action measure*	79	85	6	< 0.0001
	Women with IHD† (n = 3,533)	Men with IHD† (n = 192,038)	Difference
LDL < 100 mg/dL	67	81	14	< 0.0001
Clinical action measure*	84	89	5	< 0.0001

LDL low-density lipoprotein, IHD ischemic heart disease

*Clinical action measure defined as: LDL < 100 mg/dL; or LDL ≥ 100 mg/dL and the patient was prescribed a moderate or high-dose statin at the time of the test; or index LDL ≥ 100 mg/dL and the patient received other appropriate clinical action within 90 days. Those with no LDL test recorded, but who were prescribed a moderate or high dose statin, also passed the measure on the basis of the prescription. ^†IHD = ischemic heart disease